4//SEC Filing
Gamelin Erick 4
Accession 0000905148-25-003041
CIK 0001781174other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:16 PM ET
Size
16.4 KB
Accession
0000905148-25-003041
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2025-08-14$1.39/sh−403$560→ 15,686 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950551
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 5:16 PM ET
- Size
- 16.4 KB